OGN
Price:
$14.73
Market Cap:
$3.79B
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio consists of three immunology products, such as Brenzys, Renflexis, and Hadlima, as well as two oncology products, including Ontruzant and Aybintio. It also offers cardiovascular products, consisting of several cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Inegy, Rosuzet, and Zocor brands; Cozaar and Hyzaar for the treatment of hypert...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2021-05-14
Stock Exchange
NYSE
Ticker
OGN
According to Organon & Co.’s latest financial reports and current stock price. The company's current PE Ratio is 2.92. This represents a change of -34.01% compared to the average of 4.43 of the last 4 quarters.
The mean historical PE Ratio of Organon & Co. over the last ten years is 4.59. The current 2.92 PE Ratio has changed 6.26% with respect to the historical average. Over the past ten years (40 quarters), OGN's PE Ratio was at its highest in in the September 2023 quarter at 19.13. The PE Ratio was at its lowest in in the December 2023 quarter at 1.69.
Average
4.59
Median
3.91
Minimum
2.62
Maximum
7.74
Discovering the peaks and valleys of Organon & Co. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 49.21%
Maximum Annual PE Ratio = 7.74
Minimum Annual Increase = -53.51%
Minimum Annual PE Ratio = 2.62
Year | PE Ratio | Change |
---|---|---|
2023 | 3.60 | -53.51% |
2022 | 7.74 | 35.42% |
2021 | 5.71 | 46.44% |
2020 | 3.90 | 49.21% |
2019 | 2.62 | -33.10% |
2018 | 3.91 | -16.35% |
The current PE Ratio of Organon & Co. (OGN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
5.68
5-year avg
4.71
10-year avg
4.59
Organon & Co.’s PE Ratio is less than Johnson & Johnson (23.91), greater than Bristol-Myers Squibb Company (-16.14), less than AbbVie Inc. (62.10), less than Eli Lilly and Company (85.65), less than Pfizer Inc. (35.53), less than Amgen Inc. (33.58), less than Merck & Co., Inc. (20.73), less than Gilead Sciences, Inc. (929.81), less than Sanofi (25.51), less than AstraZeneca PLC (31.31), less than Novartis AG (11.14), less than Biogen Inc. (13.44),
Company | PE Ratio | Market cap |
---|---|---|
23.91 | $351.15B | |
-16.14 | $117.15B | |
62.10 | $317.73B | |
85.65 | $755.34B | |
35.53 | $151.34B | |
33.58 | $142.17B | |
20.73 | $251.57B | |
929.81 | $117.09B | |
25.51 | $120.51B | |
31.31 | $205.57B | |
11.14 | $192.42B | |
13.44 | $21.72B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Organon & Co. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Organon & Co. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Organon & Co.'s PE Ratio?
How is the PE Ratio calculated for Organon & Co. (OGN)?
What is the highest PE Ratio for Organon & Co. (OGN)?
What is the 3-year average PE Ratio for Organon & Co. (OGN)?
What is the 5-year average PE Ratio for Organon & Co. (OGN)?
How does the current PE Ratio for Organon & Co. (OGN) compare to its historical average?